SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610618-24-000093
Filing Date
2024-07-19
Accepted
2024-07-19 16:38:59
Documents
1
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1721421532.html 4  
1 FORM 4 wk-form4_1721421532.xml 4 4463
  Complete submission text file 0001610618-24-000093.txt   6077
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Tadvalkar Laura (Reporting) CIK: 0002020464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 241128192